Get this delivered to your inbox, and more info about our products and services.
Moderna just had its best day since October. Here's what's going on, and what analysts expect
Analysts pointed to an upcoming health care conference and cancer data study release as potential catalysts for Moderna's ongoing rally.
14 words~1 min read






